Christophe Hézode Selected Research

Lymphoproliferative Disorders (Lymphoproliferative Disorder)

10/2002

Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christophe Hézode Research Topics

Disease

51	Infections 01/2023 - 07/2007
32	Fibrosis (Cirrhosis) 01/2023 - 01/2002
29	Chronic Hepatitis C 01/2019 - 06/2002
9	Hepatitis C 10/2018 - 10/2006
6	Liver Diseases (Liver Disease) 10/2018 - 05/2007
5	Chronic Hepatitis B 10/2016 - 05/2007
4	Exanthema (Rash) 03/2014 - 04/2009
4	Pruritus (Itching) 03/2014 - 04/2009
3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 06/2010
3	Virus Diseases (Viral Diseases) 01/2017 - 06/2015
3	Anemia 03/2014 - 04/2009
2	Persistent Infection 01/2020 - 04/2009
2	Fatigue 10/2018 - 03/2014
2	Coinfection 09/2018 - 12/2009
1	Chronic Disease (Chronic Diseases) 10/2018
1	Hepatitis 09/2018
1	Substance-Related Disorders (Drug Abuse) 09/2018
1	Mental Disorders (Mental Disorder) 09/2018
1	Hepatitis B 09/2018
1	Hemorrhage 01/2017
1	Hemoglobinopathies 01/2017
1	Headache (Headaches) 03/2014
1	Nausea 03/2014
1	Cicatrix (Scar) 02/2012
1	Dermatitis 02/2012
1	Eczema 02/2012
1	Disease Progression 06/2010
1	Body Weight (Weight, Body) 04/2009
1	Hyperglycemia 02/2008
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2004
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2002

Drug/Important Bio-Agent (IBA)

36	Ribavirin (Virazole)FDA LinkGeneric 01/2023 - 04/2005
24	Antiviral Agents (Antivirals)IBA 01/2019 - 07/2007
20	InterferonsIBA 01/2020 - 12/2009
16	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2002
13	telaprevirIBA 01/2016 - 04/2009
11	daclatasvirIBA 06/2017 - 09/2012
10	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2016 - 01/2012
8	Protease Inhibitors (Protease Inhibitor)IBA 01/2018 - 02/2014
7	SofosbuvirIBA 01/2023 - 05/2014
7	peginterferon alfa-2a (Pegasys)FDA Link 01/2016 - 10/2006
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 06/2010
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 12/2004
4	Ritonavir (Norvir)FDA Link 01/2016 - 01/2015
3	grazoprevirIBA 01/2019 - 01/2017
3	elbasvirIBA 01/2019 - 01/2017
3	SimeprevirIBA 06/2017 - 02/2016
3	NucleosidesIBA 01/2017 - 04/2013
3	NucleotidesIBA 01/2017 - 04/2013
3	paritaprevirIBA 01/2016 - 06/2015
3	ombitasvirIBA 01/2016 - 06/2015
3	asunaprevirIBA 05/2015 - 01/2013
3	Interferon-alpha (Interferon Alfa)IBA 07/2007 - 04/2005
2	velpatasvirIBA 01/2023 - 12/2015
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2021 - 04/2013
2	Biomarkers (Surrogate Marker)IBA 07/2015 - 12/2004
2	8- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA 05/2015 - 02/2014
2	Erythropoietin FDA Link 11/2013 - 09/2013
2	Hepatitis B e AntigensIBA 01/2009 - 05/2007
2	Alanine Transaminase (SGPT)IBA 05/2007 - 01/2002
1	Oral ContraceptivesIBA 01/2019
1	glecaprevir and pibrentasvirIBA 01/2019
1	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 01/2019
1	Illicit Drugs (Recreational Drugs)IBA 09/2018
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	Tenofovir (Viread)FDA Link 10/2016
1	AntigensIBA 04/2016
1	2'- fluoro- 2'- methyl- 3',5'- diisobutyryldeoxycytidineIBA 01/2016
1	peginterferon lambda-1aIBA 01/2016
1	Hepatitis C AntibodiesIBA 01/2016
1	alisporivirIBA 10/2015
1	N 30IBA 06/2015
1	sofosbuvir drug combination ledipasvirIBA 04/2015
1	danoprevirIBA 01/2015
1	ApolipoproteinsIBA 10/2014
1	beta 2-Glycoprotein I (Apolipoprotein H)IBA 10/2014
1	InterleukinsIBA 02/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2012
1	EmollientsIBA 02/2012
1	HCV NS3-4A Protease InhibitorsIBA 01/2012
1	Caffeine (No Doz)FDA LinkGeneric 06/2011
1	adefovir dipivoxil (Hepsera)FDA Link 01/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2009
1	Viral ProteinsIBA 07/2008
1	adefovirIBA 05/2007
1	Lamivudine (Epivir)FDA Link 05/2007
1	Tissue Inhibitor of Metalloproteinase-1IBA 12/2004
1	Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA 12/2004
1	Hyaluronic Acid (Hyaluronan)IBA 12/2004
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 10/2002

Therapy/Procedure

26	Therapeutics 01/2021 - 04/2005
4	Liver Transplantation 01/2017 - 01/2002
3	Duration of Therapy 02/2018 - 02/2015
2	Opiate Substitution Treatment 01/2019 - 09/2018
2	Drug Tapering 11/2013 - 08/2002
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2019
1	Aftercare (After-Treatment) 10/2018
1	Ambulatory Care (Outpatient Care) 09/2018
1	Transplantation 10/2002
1	Organ Transplantation 10/2002